trial
as of 2026-07-01Alexithymia Intervention for Suicide
NCTId NCT05724953
at a glance
Phase 1 · Terminated
Enrollment 11 (actual)
Sponsored by VA Office of Research and Development
Primary completion 2026-01-30
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 1
Status
Terminated
Enrollment
11 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2023-10-01
Primary completion
2026-01-30
Eligibility
ALL · 18 Years
Interventions & indications
Sponsors
VA Office of Research and DevelopmentLead Sponsor
Investigators
1
Marianne S. Goodman, MDPrincipal Investigator
Sites
1 total
The Bronx, United States
Facts & assertions
4 sourced
Enrollment
11
Phase
PHASE1
Primary Completion Date
2026-01-30
Status
TERMINATED
relationships
The graph out of here
drug
lead_sponsor
indication
investigator
person